Breaking Boundaries in Cell Therapy:
Growth, Milestones & What’s Next
The cell therapy landscape isn’t just growing – it’s accelerating. With 487 new assets and 489 new trials emerging in H1 2025, the field is on track to explode with innovation and momentum. Perhaps most exciting is the first-ever NDA submission of a CAR T therapy for solid tumors, a watershed moment that could redefine the future of oncology, with ripple effects from China to the United States.
This milestone, along with dozens of other breakthroughs, is unpacked in detail inside the Cell Therapy H1 2025 Landscape Review – Beacon’s exclusive, data-powered report that tracks every shift in drug development, trials, and commercial strategy across the global cell therapy space.
Download your free copy today to get ahead of the curve.
Report Contents
The Drug Landscape
Explore the full drug landscape analysis, spotlight high-potential assets, and uncover where the next big breakthroughs may come from.
The Trial Landscape
Deep dive into the trial landscape, understand trial trends, sponsors, where trials are taking place, and reasons for trial terminations.
The Commercial Market
A review of cell therapy deals, mergers and acquisitions from H1 2025, as well as cell therapy company type and location.
The Future of Cell Therapy
A glimpse into the future trajectory of the cell therapy space, with a look at armoring technologies, In Vivo CAR, and upcoming milestones.
Previous Cell Therapy Landscape Reviews
Cell Therapy 2024 Landscape Review
An analysis of the Cell Therapy landscape in 2024
Cell Therapy 2024 H1 Landscape Review
An analysis of the Cell Therapy landscape in H1 of 2024
You May also be Interested in…
Learn More About Cell Therapy
- The Most Comprehensive Way to Search the Cell Therapy Development Landscape: Unique search ontologies based on Cell Therapy drug and trial characteristics
- Market Leading Approach to Cell Therapy Preclinical & Clinical Data Curation: Manual curation of key Cell Therapy research and development data points by Cell Therapy research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Cell Therapy company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
